HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Berger, J. R. Articles by Mucke, L. Search for Related Content PubMed PubMed Citation Articles by Berger, J. R. Articles by Mucke, L.

Prolonged survival and partial recovery in AIDS-associated progressive multifocal leukoencephalopathy

From the Departments of Neurology and Internal Medicine (Dr. Berger), University of Miami School of Medicine, Miami, FL, and the Department of Neurology (Dr. Mucke), Massachusetts General Hospital and Harvard Medical School, Boston, MA.

Two human immunodeficiency virus seropositive patients with progressive multifocal leukoencephalopathy (PML) exhibited a dramatic though incomplete recovery of neurologic function and have survived for more than 30 months since the onset of symptoms. PML was the initial manifestation of the acquired immune deficiency syndrome (AIDS) in both patients, though other opportunistic infections have subsequently supervened in one. Brain tissue from both patients obtained by stereotactic biopsy showed the typical features of PML, but was also characterized by an unusually prominent inflammatory response. Neurologic improvement did not appear to correlate with clinical or laboratory measurements of immunologic improvement. One patient continued to display neurologic recovery despite the development of other opportunistic infections. Though atypical, PML in AIDS may be associated with prolonged survival.

Address correspondence and reprint requests to Dr. Berger, Department of Neurology, University of Miami School of Medicine, 1501 NW 9th Avenue, Miami, FL 33136.

Received October 21,1987. Accepted for publication in final form November 23,1987.

This article has been cited by other articles:

				J R Berger Natalizumab and progressive multifocal leucoencephalopathy Ann Rheum Dis, November 1, 2006; 65(suppl_3): iii48 - iii53. [Abstract] [Full Text] [PDF]

				L. Kunschner and T. F. Scott Sustained recovery of progressive multifocal leukoencephalopathy after treatment with IL-2 Neurology, November 8, 2005; 65(9): 1510 - 1510. [Full Text] [PDF]

				N A Sibtain and R J S Chinn Imaging of the central nervous system in HIV infection Imaging, February 1, 2002; 14(1): 48 - 59. [Abstract] [Full Text] [PDF]

				M. Judith Donovan Post, C. Yiannoutsos, D. Simpson, J. Booss, D. B. Clifford, B. Cohen, J. C. McArthur, and C. D. Hall Progressive Multifocal Leukoencephalopathy in AIDS: Are There Any MR Findings Useful to Patient Management and Predictive of Patient Survival? AJNR Am. J. Neuroradiol., November 1, 1999; 20(10): 1896 - 1906. [Abstract] [Full Text]

				L. Monno, G. B Zimatore, M. Di Stefano, A. Appice, P. Livrea, and G. Angarano Reduced concentrations of HIV-RNA and TNF-alpha coexist in CSF of AIDS patients with progressive multifocal leukoencephalopathy J. Neurol. Neurosurg. Psychiatry, September 1, 1999; 67(3): 369 - 373. [Abstract] [Full Text]

				M. J. Rosas, F. Simoes-Ribeiro, S. F. An, and N. Sousa Progressive multifocal leukoencephalopathy: Unusual MRI findings and prolonged survival in a pregnant woman Neurology, February 1, 1999; 52(3): 657 - 657. [Abstract] [Full Text]

				C. D. Hall, U. Dafni, D. Simpson, D. Clifford, P. E. Wetherill, B. Cohen, J. McArthur, H. Hollander, C. Yainnoutsos, E. Major, et al. Failure of Cytarabine in Progressive Multifocal Leukoencephalopathy Associated with Human Immunodeficiency Virus Infection N. Engl. J. Med., May 7, 1998; 338(19): 1345 - 1351. [Abstract] [Full Text] [PDF]